Every month, a clear summary of what changed in regenerative medicine regulation: FDA and FTC news, state-by-state rule changes, enforcement updates, and what it means for your practice. Date-stamped and sourced, never hype.
Pricing will be announced at launch. Join now for first access and early pricing.
No spam, ever Unsubscribe anytime Educational use only
Two new warning letters issued to clinics making unapproved claims. No new approvals for the product categories covered in Genademy coursework.
Arizona clarified supervision requirements. Florida updated documentation standards. Utah proposed a change for comment.
New guidance on how claims in clinic marketing are evaluated, with examples of language regulators flag.
Three quick checks for your consent forms, website copy, and supplier documentation this month.
Warning letters, guidance, enforcement actions, and product status changes, summarized without the legalese.
Which states passed laws, updated scope rules, or opened comment periods, and what each change requires.
Every item carries its source and date, so you know exactly how current your picture of the landscape is.
Each issue closes with quick checks for your consent forms, website copy, and supplier documentation.
